Therefore, investigating how Aβ and tau burden levels influence changes in insular FC in MCI patients will not only enhance our understanding of the role of pathological burden in neural communication and information transmission during the MCI stage but also provide potential neuroimaging biomarkers for the early identification of AD. The gene discussed is MAPT; the disease is Alzheimer disease.